Prevalence of cancer and management in elderly nursing home residents. A descriptive study in 45 French nursing homes.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 21 03 2018
revised: 11 09 2018
accepted: 28 09 2018
pubmed: 30 10 2018
medline: 23 7 2019
entrez: 30 10 2018
Statut: ppublish

Résumé

This study aimed to determine cancer prevalence occurring after the age of 75 in 45 French nursing homes (NH), as well as residents' characteristics and parameters associated with cancer-specific management. Descriptive retrospective study including 214 residents (mean age, 89.7 years) with cancer diagnosed after age 75. The studied parameters were sociodemographic, functional, nutritional and cognitive data; comorbidity assessment; date of tumoral diagnosis; cancer type; tumoral stage; treatment plan; multidisciplinary staff decision and oncologic follow-up. Our results showed that cancer prevalence in NH was 8.4 ± 1.1%, diagnosed before admission in 63% of cases. The most common tumoral sites were skin (26%), digestive tract and breast (18% for both); 12% had metastasis. Cognitive impairment was the most common comorbidity (42%), and 44% of the residents were highly dependent. Multivariate analysis showed that therapeutic decisions were associated with age. Older patients had less staging exploration (odd ratios [ORs], 0.90, 95% confidence interval [CI], 0.85-0.97) and underwent less cancer-specific treatment (ORs, 0.92; 95%CI, 0.86-0.99). Oncologic follow-up was more frequent in younger patients (ORs, 0.90; 95%CI, 0.81-0.99) and those with recent diagnosis (ORs, 0.37; 95%CI, 0.23-0.61). This study identified factors associated with substandard neoplastic management in elderly NH residents. It highlights needs for information, education and training in cancer detection to improve cancer consideration and care in NH.

Identifiants

pubmed: 30370946
doi: 10.1111/ecc.12957
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Pagination

e12957

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Evelyne Liuu (E)

Department of Geriatrics, Poitiers University Hospital, Poitiers, France.
INSERM, CIC-P 1402, Poitiers University Hospital, University of Poitiers, Poitiers, France.

Nicolas Guyot (N)

Department of Geriatrics, Saintes Hospital, Saintes, France.

Simon Valero (S)

Department of Geriatrics, Poitiers University Hospital, Poitiers, France.

Amelie Jamet (A)

Department of Geriatrics, Poitiers University Hospital, Poitiers, France.

Houria El Ouazzani (HE)

Department of Analytical Chemistry, Pharmaceutics and Epidemiology, University of Poitiers, Poitiers, France.

Patrick Bouchaert (P)

Department of Medical Oncology, Poitiers University Hospital, Poitiers, France.

Jean-Marc Tourani (JM)

Department of Medical Oncology, Poitiers University Hospital, Poitiers, France.

Virginie Migeot (V)

Department of Analytical Chemistry, Pharmaceutics and Epidemiology, University of Poitiers, Poitiers, France.

Marc Paccalin (M)

Department of Geriatrics, Poitiers University Hospital, Poitiers, France.
INSERM, CIC-P 1402, Poitiers University Hospital, University of Poitiers, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH